Embla Medical Statistics

Total Valuation

Embla Medical has a market cap or net worth of DKK 11.51 billion. The enterprise value is 14.52 billion.

Market Cap	11.51B
Enterprise Value	14.52B

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Embla Medical has 426.47 million shares outstanding. The number of shares has increased by 1.51% in one year.

Current Share Class	n/a
Shares Outstanding	426.47M
Shares Change (YoY)	+1.51%
Shares Change (QoQ)	-3.47%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	73.84%
Float	161.07M

Valuation Ratios

The trailing PE ratio is 23.42 and the forward PE ratio is 21.12. Embla Medical's PEG ratio is 0.96.

PE Ratio	23.42
Forward PE	21.12
PS Ratio	1.87
PB Ratio	2.05
P/TBV Ratio	n/a
P/FCF Ratio	17.95
P/OCF Ratio	13.77
PEG Ratio	0.96

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.11, with an EV/FCF ratio of 22.64.

EV / Earnings	29.52
EV / Sales	2.36
EV / EBITDA	12.11
EV / EBIT	17.21
EV / FCF	22.64

Financial Position

The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.64.

Current Ratio	1.90
Quick Ratio	1.03
Debt / Equity	0.64
Debt / EBITDA	3.06
Debt / FCF	5.61
Interest Coverage	4.89

Financial Efficiency

Return on equity (ROE) is 9.28% and return on invested capital (ROIC) is 5.80%.

Return on Equity (ROE)	9.28%
Return on Assets (ROA)	4.86%
Return on Invested Capital (ROIC)	5.80%
Return on Capital Employed (ROCE)	8.55%
Revenue Per Employee	1.52M
Profits Per Employee	121,112
Employee Count	4,061
Asset Turnover	0.58
Inventory Turnover	2.29

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.53% in the last 52 weeks. The beta is 0.57, so Embla Medical's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-16.53%
50-Day Moving Average	29.74
200-Day Moving Average	32.28
Relative Strength Index (RSI)	45.01
Average Volume (20 Days)	66,305

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Embla Medical had revenue of DKK 6.16 billion and earned 491.84 million in profits. Earnings per share was 1.15.

Revenue	6.16B
Gross Profit	3.85B
Operating Income	819.42M
Pretax Income	652.37M
Net Income	491.84M
EBITDA	993.48M
EBIT	819.42M
Earnings Per Share (EPS)	1.15

Full Income Statement

Balance Sheet

The company has 620.67 million in cash and 3.60 billion in debt, giving a net cash position of -2.98 billion or -6.99 per share.

Cash & Cash Equivalents	620.67M
Total Debt	3.60B
Net Cash	-2.98B
Net Cash Per Share	-6.99
Equity (Book Value)	5.62B
Book Value Per Share	13.11
Working Capital	1.35B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 836.08 million and capital expenditures -194.73 million, giving a free cash flow of 641.35 million.

Operating Cash Flow	836.08M
Capital Expenditures	-194.73M
Free Cash Flow	641.35M
FCF Per Share	1.50

Full Cash Flow Statement

Margins

Gross margin is 62.55%, with operating and profit margins of 13.31% and 7.99%.

Gross Margin	62.55%
Operating Margin	13.31%
Pretax Margin	10.59%
Profit Margin	7.99%
EBITDA Margin	16.13%
EBIT Margin	13.31%
FCF Margin	10.41%

Dividends & Yields

Embla Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.51%
Shareholder Yield	-1.51%
Earnings Yield	4.27%
FCF Yield	5.57%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Embla Medical has an Altman Z-Score of 3.17.

Altman Z-Score	3.17
Piotroski F-Score	n/a